December 1, 2011
The US FDA approved Ranbaxy Laboratories of India’s generic versions of the hyperlipidemia treatment Lipitor (atorvastatin) on November 30. With the advent of generics for Lipitor, the world’s largest blockbuster, Pfizer Inc. has reached the patent cliff. Ranbaxy launched its...read more